Recently, many concerns are paid for dual action drugs such as ACE/NEP dual inhibitors which have two different biological activities. To identify multiple active drugs by supervised learning approach, a multi-label classification technique is required. In the present work, we investigated the classification of antihypertensive drugs including ACE/NEP dual inhibitors using support vector machines (SVMs). Biological activity data of the drugs were taken from the MDDR database and they were employed for the computational trial for the training of the SVM classifiers. Structural feature representation of each drug molecule was based on topological fragment spectra (TFS) method. The obtained classifiers were tested for finding ACE/NEP dual inhibitors. The result suggests that the TFS-based SVM classifiers are useful for finding multiple active drugs such as ACE/NEP dual inhibitors.
Introduction
Angiotensin converting enzyme (ACE) and neutral endopeptidase (NEP) are individually major therapeutic targets for the treatment of hypertension. Recently, more attention has been paid for ACE/NEP dual inhibitors as a new type of antihypertensive drugs [1] [2] [3] . The dual inhibitors act on both ACE and NEP. Nowadays, rational drug discovery techniques are strongly required to find a new class of drugs such as cyclooxygenase (COX) and lipoxygenase (LOX) inhibitors [4] [5] [6] as well as the ACE/NEP inhibitors. To achieve its aim, multi-label classification techniques [7] [8] [9] are required. Multi-label classification can be used to identify the drugs that have two or more different biological actions such as ACE/NEP dual inhibitors. On the other hand, target selective drugs such as ACE selective inhibitors may also be identified by means of multi-label classification technique.
Multi-label classification has been actively investigated especially in the field of text categorization [7] [8] , but applications in chemical data analysis are relatively limited. One of the relevant works was reported by Hristozov et al. [10] in which they applied k-nearest neighbor based method to identify the plant sources of sesquiterpene lactones. The PASS [11] [12] developed by Poroikov and co-workers is a sort of multi-label classifier. The PASS employed a statistical method to predict multiple biological actions of a drug. It was applied to finding novel ACE/NEP dual inhibitors from commercially available compounds [13] . Another study was reported by Nidhi et al. [14] in which they applied Bayesian models to predict the biological targets of a drug. The Bayesian models output the classification results with the probabilities which a compound may belong to individual activity classes of our interest. This point is an advantage because the thresholds to distinguish between active and inactive can be defined by the user. On the other hand, the rule to determine the thresholds is ambiguous.
SVM was successfully applied to the classification of biological activity of drugs [15] [16] . In addition, SVM deterministically classify the instance being "active" or "inactive" on the basis of the discriminant surface that was determined in advance. In the previous studies [15] [17], we investigated the classification of dopamine agonists and antagonists, in which each drug belongs to a single class. It was shown that SVM performed better than the artificial neural networks with multiple output neurons [15] , and the SVM in conjunction with topological fragment spectra (TFS) descriptors, we called TFS-based SVM, could successfully learn the relationships between chemical structures of the drugs and their biological activity. The authors also reported that the TFS-based SVM approach applied to biological activity profiling of drugs including multi-label compounds [18] .
In the present study, we investigated identification of the action mechanisms of antihypertensive drugs by means of the TFS-based support vector machines. The illustrative scheme of our work is shown in Figure 1 . We also discuss the possibility for finding a new class of drugs such as ACE/NEP dual inhibitors. Each chemical structure is characterized by the TFS method and their biological activities are predicted by SVMs. If the classification results in the ACE inhibitor = 1 and NEP inhibitor = 1, the drug is considered as ACE/NEP dual inhibitor. The aim is to predict some action mechanisms of antihypertensive drugs using TFS-based SVMs.
Data Set and Methods

Data Set
MDDR [19] is an appropriate data source for use in this work. It is a structure database of biologically active drugs, which are collected from patents, journals, meetings, etc. In this work, we employed 7,939 antihypertensive drugs, which belong to one or more of 18 different activity classes. Details of the preparation of the data set are described below.
The MDDR database (release 2001.1) consists of 119,110 compounds, and each compound is labeled by one or more classes of 701 activities. First, we searched 10,510 antihypertensive drugs from the database. Then, the chemical structures were desalted if they were salts, and the compounds that had more than 50 heavy atoms were removed. This treatment was employed to remove large molecules such as natural products and peptides. We also removed the classes that have the small number of entries. As a result, we focused on 18 classes which have 200 or more entries, because the training set of enough number of data are required to get a successful classification model. We checked the data set and found that 5,707 compounds were single-label data and 2,232 compounds were multi-label data. Then, the data set was split for the three-fold cross validation. The details are shown in Table 1 . The largest number of activity class labels of a single compound was four in the present data set. The list of the targeted activity class labels is shown in Table 2 . It should be noticed that they include both molecular targets and therapeutic areas related to hypertension. In other words, they include action mechanism and disease name. Table 1 . Data sets used in the present study. 1) Number of compounds in the training set.
2) Number of compounds in the validation set. set 1 set 2 set 3 number of class labels training set 1) validation set 2) training set validation set training set validation set  1  3815  1892  3803  1904  3796  1911  2  1271  658  1279  650  1308  621  3  193  90  197  86  176  107  4  13  7  14  6  13  7  total  5292  2647  5293  2646  5293  2646 
Support Vector Machine
SVM [20] has become popular as a powerful classifier in the past decade. Basically, SVM is a binary classifier and separate the data space by a hyperplane that is defined by a mathematical function called discriminant function. Suppose there is a data set represented by (x 1 , ..., x i , ..., x n ), where x i is a pattern vector and n is the number of patterns, and those patterns are linearly separable with class labels y i {-1,1}, i = 1, ..., n. In this case, the discriminant function can be written in the form:
Where w is a weight vector and b is a bias. When the discriminant function is f(x i )=0, it shows the discriminant surface. The discriminant surface with the maximum margin can be found by minimizing ||w|| 2 with constraints,
This idea can be generalized to a linearly inseparable case by introducing Lagrangian multipliers and by using the concept of nonlinear mapping by a kernel function. The kernel function maps the input vectors x into a higher dimensional feature space through some nonlinear mapping chosen a priori. In this space, an optimal discriminant hyperplane with a maximum margin is constructed. Finally, the discriminant function of interest can be described as Equation (2):
In Equation (2),  i is a Lagrangian multiplier, y i is a class label, C is a regularization parameter, and K(x, x i ) is a kernel function for mapping the data into a higher dimensional feature space. In the present work, we used a radial basis function shown in Equation (3) as the kernel function.
Appropriate values of the parameters  and C were determined by a simple grid search method.
In this work, all of the computations for the SVM training were carried out using an in-house software tool based on Platt's SMO algorithm and the pseudocode reported in the literature [21] .
Classification rules
To identify multiple active drugs, a multi-label classification technique is required. In the multi-label classification, each example can be classified into a single class, multiple classes, or not be classified into any of the classes. In other words, there is not always one-to-one correspondence between a compound and its biological action. The most common approach to the multi-label classification can be accomplished by means of a combination of plural binary classifiers which were trained for individual classes. Then a compound is assigned to the classes in which the corresponding model classified as "active". Thus, this approach requires the binary classifiers as many as the activity classes to be considered.
To perform this, each SVM was trained to separate the object compounds associated with a class of the interest from the others (Figure 2 ). Eighteen SVM classifiers were developed for the present work, and the collective classifiers were used for the multi-label classification of the antihypertensive drugs. In this study, the multi-label problem is decomposed into 18 binary problems.
Feature Representation of Chemical Structures
We employed Topological Fragment Spectra (TFS) method [22] to describe the structural features of a drug molecule. TFS is represented as a multidimensional pattern vector. The TFS pattern vector is obtained by the enumeration of all possible substructures (or structural fragments) that have a specified number of bonds and the characterization of the fragments with numerical quantity. An illustrative example of the TFS is shown in Figure 3 .
In the present work, we enumerated all the possible structure fragments that have five or less connected bonds in the hydrogen suppressed graph expression. All of the fragments were characterized by the sum of atomic mass numbers of the constituent atoms. For the characterization, we took the attached hydrogen atoms into account. Then, the occurrence of individual fragments with the same characteristic value (mass number) was counted, and they were sorted according to the fragment mass number. Thus, every chemical structure was represented by a 182 dimensional numerical vector. First, enumerate all possible fragments of the given structure (2-methoxypropane). The number of edges of the fragments is described as S(e). Then, characterize the fragments by a numerical quantity such as sum of mass numbers, degrees of the nodes, etc. The frequency distribution of characterized fragments is defined as a TFS.
Evaluation of the classification performances
In a binary classification problem, the classification result of each example is categorized into true positive (TP), true negative (TN), false positive (FP) or false negative (FN). The performance of each SVM classifier was evaluated using the following measurements: sensitivity, specificity and selectivity. 
In every measurement, the larger value shows the better performance. Sato et al. [23] described that accuracy (TP + TN)/(TP + FP + TN + FN) is not an appropriate measure when applying to unbalanced data. Obviously, the data set of the present study is unbalanced because the number of positive examples is much smaller than that of negative examples in every case. In such cases, balanced accuracy and kappa statistics are often used [23] . Balanced accuracy is an average of the sensitivity and the specificity. In the model generation process, we used the sum of sensitivity and specificity (which is equivalent to the balanced accuracy in the basic sense) to determine the appropriate values of individual parameters for each of the SVM classifiers.
Results and Discussion
Model Generation and Predictive Performance
Using a training set and a validation set, we tried to determine the suitable value of  for the Gaussian kernel function and a regularization parameter C for each class. These parameter values were determined to maximize the sum of sensitivity and specificity against the validation set by means of a conventional grid search method. Classification ability of each model was estimated by the three-fold cross validation. The details of those training and prediction results are shown in Table 2 .
It is obvious that the higher selectivity is obtained when the number of overpredictions (false positives) is small. The results show that the training was really successful because the average sensitivity, specificity and selectivity were 0.989, 0.996 and 0.963 respectively. For the prediction, sensitivity ranged from 0.773 to 0.964 (average was 0.866), specificity ranged from 0.945 to 0.999 (average was 0.980) and selectivity ranged from 0.590 to 0.992 (average was 0.775). The average selectivity of 0.775 indicates that the obtained model correctly identified multiple biological actions of the drugs without too many false positives. These results suggest that the TFS-based support vector machines provide us good models for the classification of various types of antihypertensive drugs.
On the other hand, the results also suggest that the sensitivities for the classes of action mechanisms (Nos. 1-9 in Table 2 ) would be much higher than those of disease name or biological readout classes (Nos. 10-18 in Table 2 ). Because plural therapeutic targets would be found for a particular disease, it is expected that disease name classes may have much more structurally diverse drugs. In fact, the highest sensitivity was obtained for renin inhibitors (No. 4), while the lowest sensitivity was obtained for cardiotonic (No. 10) for the validation set. In addition, the average sensitivity of the action mechanism classes was 0.907, and that of the disease name classes was 0.826 for the validation set. The average specificity was 0.982 for the action mechanisms classes and 0.978 for the disease name classes. They were almost the same. Concerning selectivity, the average value of the action mechanism classes (0.822) was higher than that of the disease name classes (0.732). Thus, it can be considered that the predictions for the action mechanisms classes are easier than those for the disease name classes. 
Identification of ACE/NEP Dual Inhibitors
Finding a new class of drugs is one of active areas in the drug discovery and development. As described above, both ACE and NEP are known as therapeutic targets for antihypertensive drugs. It was also proved by a clinical trial that the ACE/NEP dual inhibitor is an effective antihypertensive [2] . Therefore, identification of the ACE/NEP dual inhibitors is a good example of the practical use of the multi-label classification for exploring a new class of drugs.
The results for classification and identification of the ACE/NEP dual inhibitors are summarized in Table 3 . For the first set (set 1), the computational experiment was carried out by the collective SVM classifiers that were trained with 5,292 antihypertensive drugs including 127 ACE/NEP dual inhibitors. The classifiers correctly classified 125 of the dual inhibitors. The validation set that consists of 2,647 antihypertensive drugs including 69 ACE/NEP dual inhibitors. In this trial, the classifiers predicted 86 compounds as dual inhibitors, and 61 of them were correctly identified, i.e. sensitivity and selectivity were 0.88 and 0.71 respectively.
The computational trials were also carried out for the set 2 and set 3. For the set 2, sensitivity, specificity and selectivity were 0.93, 0.98 and 0.56 respectively. In the same way, for the set 3, those measurements were 0.82, 0.99 and 0.64 respectively ( Table 3 ). The results suggest that the TFS-based support vector machines can be used to explore new drug candidates such as dual action drugs. 
Predictive Ability of Dual Inhibitors and Similarity
Usually, it is easy to identify the activity classes of a query compound when we have a lot of similar compounds in the training data. Therefore, we investigated the distance between query compound and the nearest example of the dual inhibitors in the training set. The average value of those distances for both correctly classified compounds and misclassified compounds was computed for each set. The results are summarized in Table 4 . It clearly shows that more similar compounds in the training set increases the classification performance.
In further analysis, we examined five most distant pairs of the query compound and their nearest training example. The obtained model misclassified all of five cases. Table 5 shows the query, the nearest example and the Euclidean distance between them. Intuitively, the molecular frameworks of each pair are different, especially for No. 2, 3 and 4. Additionally, it is clear that every scaffold pair differs in terms of non-terminal vertex graph (NTG) [24] . The NTG is defined as a vertex graph, which does not have any terminal vertex or any isolated vertex. It is considered that the class identification of such compounds were quite hard because similar data were not available in the training set. Table 5 . Structural examples of validation compound and nearest training dual inhibitor.
The five examples were chosen in descending order of Euclidean distance between the validation set compound and the nearest training compound. The figure attached above the structure is an EXTREG number of MDDR database.
No. query in the validation set the nearest example in the training set distance 
Conclusions
In this paper, we discussed multi-label classification of the drugs that may have two or more labels of individually different biological actions. The collective SVM classifiers in conjunction with the TFS descriptors successfully classified antihypertensive drugs that belong to one or more of 18 different classes. The classifiers also successfully identified the ACE/NEP dual inhibitors without too many false-positives. Those results show that the multi-label classification using the TFS-based support vector machines can provide us a possible tool to explore new types of multiply active drugs such as ACE/NEP dual inhibitors from chemical libraries.
